While BAP1 mutation correlated with decreased survival across the entire cohort (p = 0.0002) and within the ccRCC group (p = 0.0035), BAP1 mutation did not correlate with survival in PRCC or ChRCC. This evidence concerns the gene BAP1 and chromophobe renal cell carcinoma.